Yosuke Sugiyama

Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis

Toshiki Etani, Taku Naiki, Yosuke Sugiyama et al. · Oncology · 2020 · 29 citations

A Retrospective Study on the Effectiveness of Switching to Oral Methadone for Relieving Severe Cancer-Related Neuropathic Pain and Limiting Adjuvant Analgesic Use in Japan

Yosuke Sugiyama, Nobuhiro Sakamoto, Masahiro Ohsawa et al. · Journal of Palliative Medicine · 2016 · 25 citations

Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study

Yoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto et al. · Cancer Medicine · 2023 · 22 citations · Full text

Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis

Teruki Isobe, Taku Naiki, Yosuke Sugiyama et al. · International Journal of Clinical Oncology · 2021 · 17 citations

Metastatic Urothelial Cancer, Surgical Oncology, Urology +7

Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysis

Taku Naiki, Kiyoshi Takahara, Toshiki Ito et al. · International Journal of Clinical Oncology · 2021 · 15 citations

Urology, Health Sciences, Medicine +7